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Abstract  
Prospective data on depressive symptoms and blood pressure (BP) are scarce, and the impact of 
age on this association is poorly understood. The present study examines longitudinal 
trajectories of depressive episodes and the probability of hypertension associated with these 
trajectories over time. Participants were 6,889 men and 3,413 women London based civil 
servants, aged 35-55 years at baseline, followed for 24 years between 1985 and 2009. 
Depressive episode (defined as scoring 4 or more on the General Health Questionnaire-
Depression subscale or using prescribed antidepressant medication) and hypertension 
(systolic/diastolic blood pressure ≥ 140/90 mm Hg or use of antihypertensive medication) were 
assessed concurrently at five medical examinations. In the fully adjusted longitudinal logistic 
regression analyses based on Generalized-Estimating-Equations using age as the time scale, 
participants in the “increasing depression” group had a 24% (p<0.05) lower risk of hypertension 
at ages 35-39, compared to those in the “low/transient depression” group. However, there was a 
faster age-related increase in hypertension in the “increasing depression” group, corresponding 
to a 7% (p<0.01) greater increase in the odds of hypertension for every each five-year increase 
in age. A higher risk of hypertension in the first group of participants was not evident before age 
55. A similar pattern of association was observed in men and women although it was stronger in 
men. This study suggests that the risk of hypertension increases with repeated experience of 
depressive episodes over time and becomes evident in later adulthood. 
 
Key words: Depression, hypertension, longitudinal analysis, repeated measures  
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INTRODUCTION  
The impact of depression on the development and prognosis of chronic diseases such as 
coronary heart disease (CHD) has attracted significant research attention in recent years.  In 
healthy populations, long-term prospective studies have found depression
 
to be associated with 
the development of CHD, independently of other coronary risk factors.
1-3
 Successive meta-
analyses 
1, 4, 5
 show a pooled relative risk between 1.6 and 1.8 for incident CHD in subjects with 
depressive symptoms or diagnosed depression.  However, the mechanisms underlying the 
association between depressive disorders and CHD remain unclear. 
Hypertension or high blood pressure (BP) often accompanies psychological stress 
6
 and 
has therefore been posited as a candidate mechanism for the depression-CHD link 
7
. Several 
studies have examined the association between depressive disorder (or symptoms) and blood 
pressure, but the findings are mixed. While some studies found an association between increased 
BP / hypertension and depression symptoms,
8-11
 others reported no such association
12, 13
 or
 
found an inverse association such that lower blood pressure was observed in depressed patients 
9, 14-18
. However, most of these studies have important limitations, such as a cross-sectional 
design 
9, 15, 16, 18-20
, low statistical power, a restricted age range (elderly populations) 
16, 17, 19, 20
, or 
lack of repeated measures for blood pressure or depression
8, 9, 15, 16, 18, 19
. 
The present study takes advantage of five waves of medical screening data from the 
British Whitehall II study to examine prospectively the associations between trajectories of 
depressive episodes assessed at five points in time over a 24-year period with hypertension 
assessed at five clinical examinations over the same period of follow-up. 
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MATERIAL & METHODS 
Data are drawn from the Whitehall II study, established in 1985 as a longitudinal study 
to examine the socioeconomic gradient in health and disease among 10,308 civil servants (6,895 
men and 3,413 women). All civil servants aged 35-55 years in 20 London-based departments 
were invited to participate by letter and 73% agreed. The first screening (Phase 1) took place 
during 1985-1988, and involved a clinical examination and a self-administered questionnaire. 
Subsequent phases of data collection have alternated between postal questionnaire alone [Phases 
2 (1989-1990), 4 (1995-1996), 6 (2001) and 8 (2006)) and postal questionnaire accompanied by 
a clinical examination (Phases 3 (1991-1993), 5 (1997-1999), 7 (2002-2004) and 9 (2007-
2009)]. All participants gave consent to participate and the University College London ethics 
committee approved this study. 
 
Measures 
Assessment of depressive episodes at phases 1, 3, 5, 7, 9 
The General Health Questionnaire is used to detect minor psychiatric disorders in non-
psychiatric populations 
21
. Symptoms of depression were measured using a four-item scale 
(Cronbach α=0.88) derived from the 30-item GHQ, which has been validated within the 
Whitehall II study 
22
 based on principal components factor analysis and a comparison with the 
seven-item severe depression subscale from the 28-item GHQ 
23
. At each phase, respondents 
were considered as having depressive episode if they scored 4 or more on the depression 
subscale or reported the use of prescribed antidepressant medication 
23
. 
Assessment of hypertension at phases 1, 3, 5, 7, 9 
Systolic BP (SBP) and diastolic BP (DBP) were measured twice in the sitting position 
after 5 minutes of rest with the Hawksley random-zero sphygmomanometer at phases 1, 3, and 5 
and OMRON HEM 907 at phases 7 and 9 
24
. For the analyses, hypertension was defined 
according to the seventh report of the Joint National Committee on Prevention, Detection, 
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Evaluation, and Treatment of High Blood Pressure (systolic/diastolic >=140/90 mm Hg or use 
of antihypertensive medication) 
25
. 
Age as time scale  
As we wanted to model the age-related probability of hypertension as a function of 
depressive-episodes-trajectory groups, we used age rather than the phase of data collection as 
the time scale in the longitudinal analysis (i.e., the age recorded for each participant at the time 
of each phase). Participants were 35-55 years old at phase 1 (baseline) and 55-80 years old at 
phase 9. This implies that the participants provided data across the whole age range (35-80) as a 
function of their age between the baseline and the last follow-up. To allow estimates of the 
probability of hypertension as a function of age, we created five-year age categories as follows: 
35-39, 40-44, 45-49, 50-54, 55-59, 60-64, 65-69, 70-74, 75-80 years.  
            Covariates  
            Sociodemographic measures  
Sociodemographic measures included sex, ethnicity, marital status and socioeconomic 
status (SES) assessed by British civil service grade of employment taken from the baseline 
(phase 1) questionnaire.  
Biobehavioural risk factors  
Biobehavioural risk factors were assessed using responses to the baseline (phase 1) 
questionnaire and categorised as follows: smoking status (never, former, and current), physical 
activity (≥1.5 or <1.5 hours of moderate or vigorous exercise/week), high alcohol consumption 
in the previous
 
week (14+ units
 
for women/21+ units for men). Biological risk factors were 
assessed at phase 1 clinical examination and included body mass index (BMI) (<20, 20-24.9, 
25-29.9, or ≥30 kg/m2), high total blood cholesterol (≥ 5 mmol/l). History of chronic medical 
conditions including diabetes, myocardial infarction, stroke and cancer were assessed at phase 1 
questionnaire via self-reports of doctor diagnosis.  
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Statistical analysis 
The statistical analysis included the following steps. First, we modelled trajectories of 
depressive episodes by using the SAS procedure PROC TRAJ 
26
 that separates individuals into 
trajectory groups, here based on the depressive episode status (yes/no) of each participant at 
each of five assessment points (phases) over the 24-year follow-up period.  We identified two 
distinct trajectories of depressive episodes: the first trajectory composed of 88.7% of the study 
sample and was characterized by participants with no or few depressive episodes during the 
entire study period, the “low/transient depression” group. In this group, the prevalence of 
depressive episodes at the 5 successive follow-ups was: 9.0%, 7.9%, 5.5%, 4.0% and 3.0%. The 
second trajectory, labelled the “increasing depression” group, was composed of 11.3% of the 
study population and included participants with an increase in the number of depressive 
episodes over time; 50.4%, 40.3%, 65.8%, 74.6% and 66.0% at the five follow-ups, 
respectively. Details on the construction of these two trajectory groups are available elsewhere 
(please see http://hyper.ahajournals.org, appendix 1).    
Second, we examined differences in the two trajectory groups (defined by depressive 
episodes) as a function of baseline sociodemographic and biobehavioral covariates using the 
chi-square statistic and a one way analysis of variance. 
Third, we examined associations between covariates and hypertension status at baseline 
and over the follow-up period by fitting longitudinal logistic regression models implemented 
with generalized estimating equations (GEEs)
27
. In these models, the dependent variables were 
the five repeated measures of hypertension over the 24-year period of follow-up. Separate 
models were fitted that estimated an effect of age, modelled as a 5-year increase in age, and sex 
together with their interaction. Subsequent models additionally included: 1) the 
sociodemographic and biobehavioral covariates, and 2) the interactions between each covariate 
and age. Only associations with a p<0.05 were retained as covariates in subsequent analyses.  
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Fourth, to examine the association between trajectory groups (defined by depressive 
episodes) and hypertension over the follow-up period, we fitted four sequential longitudinal 
logistic regression models using GEEs. In model 1, age, trajectory groups, interaction term 
between trajectory groups and age were the predictor variables, adjusting for sex, interaction 
between sex and age, ethnicity and socioeconomic status. Models 2 and 3 are as model 1 but 
additionally adjusted for biobehavioural risk factors and their interactions with age (when 
significant at p<0.05), and for chronic medical conditions and their interactions with age when 
significant at p<0.05, respectively. Model 4 simultaneously adjusted for all aforementioned 
variables and their interactions with age.  The results of the GEE-analyses are presented as odds 
ratios (ORs) with 95% confidence intervals (CI). We show results from analyses stratified by, 
and adjusted for, sex. Finally, we illustrated graphically the relationship between depressive 
episodes trajectories and the risk of hypertension over time using predicted probabilities from 
the GEE-analyses at ages 35-39, 40-44, 45-49, 50-54, 55-59, 60-64, 65-69, 70-74, 75- 80 in men 
and women. 
RESULTS 
Prevalence of depressive episodes and hypertension across phases 
The prevalence of depressive episodes remained largely unchanged across the study 
phases (not shown in the tables): 13.9% at phase 1 (baseline), 11.6% at phase 3, 13.9% at phase 
5, 14.1% at phase 7 and 12.1% at phase 9 (p=0.372). In contrast, there was a clear increase in 
the prevalence of hypertension over the course of the study: 19.3% at Phase 1, 17.9% at phase 3, 
27.1% at phase 5, 39.5% at phase 7, and 46.8% at phase 9 (p<0.001)(not shown in the tables). 
Trajectory groups (defined by depressive episodes) and baseline characteristics 
Table 1 presents the baseline characteristics of the two trajectory groups. Compared to 
the “low/transient depression” group, participants in the “increasing depression” group had 
lower BMI, were younger, less physically active, more likely to be female, more likely not to be 
married/cohabiting, high alcohol consumers, and from the lower SES group (all p≤0.022). 
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Baseline covariates and risk of hypertension over time 
Table S1 shows the associations between baseline covariates, their interaction with time 
(here age) and hypertension over time (please see http://hyper.ahajournals.org, Table S1). The 
odds ratio (OR) for age was 1.36 (p<0.001) indicating that the odds for hypertension increased 
by 36% for every five-year increase in age over the follow-up. At ages 35-39, women had lower 
odds for hypertension than men (p<0.001) but it increased more rapidly with age in women than 
in men (an excess increase of 9% for every five-year increase in age, p<0.001). Non-white 
(p<0.01), non-married/cohabiting (p<0.001) and low SES participants (p<0.001) had higher 
odds for hypertension at ages 35-39, but for the latter two covariates, the increased odds for 
hypertension overtime decreased by 5% and 4% respectively for every five-year increase in age. 
Current smokers had lower odds of hypertension at ages 35-39 (p<0.01), but they experienced 
greater increase over time compared to those who had never smoked (an excess increase of 6% 
for every five-year increase in age, p<0.01). Participants above the lowest weight category had 
higher odds ratios for hypertension (p≤ 0.001) and there was a suggestion that these increased 
with age.  Participants with high total blood cholesterol level had higher odds for hypertension 
(p< 0.001) and this did not differ by age. Participants with a history of cancer at ages 35-39 have 
a much reduced odds of hypertension (p<0.01) it increased by 17% for every 5 years increase in 
age (p<0.05).  
Trajectory groups (defined by depressive episodes) and risk of hypertension over time 
Table 2 presents the risk of hypertension over time in the “increasing depression” group 
compared to that in the “low/transient depression” group. This analysis is based on 40 599 
observations over the follow-up among 10302 participants (6389 men and 3413 women). After 
adjustments for sex, interaction between sex and age, ethnicity, marital status, interaction 
between marital status and age, SES and interaction between SES and age (model 1), 
participants in the “increasing depression” group had reduced odds for hypertension at ages 35-
39 (OR=0.75, 95% CI, 0.61-0.92). However, the statistically significant interaction term with 
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age suggests that this group experienced greater increase in the risk for hypertension with 
advancing age; an excess increase of 7% (95% CI, 3-12) in the odds for hypertension for every 
five-year increase in age. Further adjustments for physical activity, smoking, interaction 
between smoking and age, BMI, and total cholesterol (model 2), diabetes, history of myocardial 
infarction, history of stroke, history of cancer, interaction between history of cancer and age 
(model 3) and for all aforementioned variables and interactions (model 4) did not alter these 
associations.  The pattern of results was similar in men and women although the associations 
were somewhat stronger in men than in women.  
Figures S2 (men) and S3 (women) [please see http://hyper.ahajournals.org, Figures S2 
and S3] show that the probability of hypertension in the low/transient and increasing depressive 
episode groups increased with increasing age, but with the size of the increase differing between 
the groups. Thus, the probability for hypertension between the ages of 35 and 55 years was 
slightly lower among participants in the “increasing depression” group, both in men and 
women, compared to those in the “low/transient depression” group. However, at ages 50-54 the 
prevalence of hypertension increased more rapidly among men in the “increasing depression” 
group, leading to higher probability of hypertension at the end of the follow-up in this group. In 
women, this seems to occur much later. 
Sensitivity analysis 
In order to test the robustness of our findings, we undertook several sensitivity analyses. 
First, we excluded the use of antidepressant and antihypertensive medications from the 
definition of depressive episode (a score ≥ 4 on the depressive symptoms scale) and 
hypertension (systolic/diastolic blood pressure ≥ 140/90 mm Hg) respectively. In analysis 
adjusted for covariates, as in Model 4 of the main analyses, we found a similar pattern of 
associations to that reported in the main analysis. Participants in the “increasing depression” 
group had reduced odds of hypertension at ages 35-39 (OR=0.69, p<0.01) compared to those in 
the “low/transient depression” group. However, this group experienced a greater increase in the 
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risk for hypertension with advancing age; an excess increase of 7% (p<0.01) for every five-year 
increase in age.  
Secondly, we excluded participants using antidepressant and antihypertensive 
medications from the analyses (n observations = 28024) and found the associations to be close 
to those reported in the main analysis and the first sensitivity analysis. Here again, participants 
in the “increasing depression” group had reduced odds for hypertension at ages 35-39, 
(OR=0.69, p<0.05) compared to those in the “low/transient depression” group. However, this 
group experienced a greater increase in the risk for hypertension with advancing age; an excess 
increase of 8% (p<0.05) for every five-year increase in age. These findings suggest that the 
associations observed in the main analysis are unlikely to be driven by antidepressant and/or 
antihypertensive medications.  
Thirdly, we undertook further analysis using an alternative definition of depressive 
episodes trajectories. This was based on the number of depressive episodes over the five 
assessments, calculated for each participant. Longitudinal logistic regression analyses with GEE 
revealed that participants with 3-5 depressive episodes had a slightly lower odds of hypertension 
at ages 35-39 (0.70, 95% CI 0.53-0.94) compared to those with no depressive episodes, but a 
steeper increase in risk with advancing age (excess odds 9%, 95% CI 3-15 for each five-year 
increase in age). No difference in the risk of hypertension was observed between participants 
with 1-2 depressive episodes and those with no such episodes. These results are highly 
consistent with those reported in the main analyses using trajectories of depressive episodes, 
demonstrating the importance of recurrent or chronic depressive symptoms for hypertension risk 
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DISCUSSION 
In this study, we sought to examine longitudinal associations between trajectories of 
depressive episodes and risk of hypertension, both assessed five times over a 24-year follow-up 
period. In the longitudinal analysis, adjusted for sociodemographic characteristics, participants 
in the “increasing depression” group had a 25% lower risk of hypertension at ages 35-39 when 
compared to those in the “low/transient depression” group. However, there was a faster age-
related increase in hypertension in the “increasing depression” group, corresponding to a 7% 
greater increase in the odds of hypertension for every five-year increase in age. Thus, the risk of 
hypertension in participants in the “increasing depression” group at the end of the follow-up 
was substantially higher than that in the "low/transient" group. This pattern of association was 
observed in both men and women even though the associations were stronger in men. 
Findings in context of the literature 
Several studies that have examined the association of depressive disorders (and 
symptoms) with blood pressure have produced mixed findings 
8-10, 12-20
 . Our data suggest that 
cross-sectional assessment of both depressive symptoms and hypertension may partly account 
for these inconsistencies in the existing literature. As far as we are aware, our study is the first to 
examine the associations between longitudinal patterns of depressive episodes and risk of 
hypertension in a large population of adults where both measures were assessed repeatedly over 
time. As depressive episodes tend to fluctuate over time and there is a general age-related 
increase in blood pressure levels, with substantial inter-individuals variation 
28, 29
 , it is crucial to 
use longitudinal data to examine the dynamics between depressive symptoms and hypertension. 
Using a longitudinal modelling approach we were able to accounting for the effect of advancing 
age on the risk of hypertension., extending previous research where depressive symptoms at 
baseline were used to predict incident hypertension during the follow-up
12, 13, 30
.  
Overall, in our study, the risk of hypertension associated with age increased more rapidly 
among participants who experienced more depressive episodes than among those with low 
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levels of depressive episodes. This is in line with the idea that continuing psychological distress 
has clinically relevant physiological effects 
30,31
. Nevertheless, our finding of a low risk of 
hypertension before the age of 55 (in men) which increases thereafter is in contrast with other 
studies. A large cross-sectional study including individuals aged 20 to 89 years found no age 
differences in the inverse association between depression and BP
15
 . In addition, a recent 
prospective study found that depression was associated with increased risk of hypertension in 
middle-aged but not in elderly individuals
11
. 
Our longitudinal analysis showing a greater increase in the risk of hypertension among 
individuals with high depression levels over time lends support to the hypothesis that depressive 
disorder (or symptoms) may increase BP levels and lead to hypertension
8-10
. Several plausible 
mechanisms may explain this association. First, as hypertension develops over a long time span, 
it may be that depressive symptoms in the long- rather than the short-term influence risk of high 
BP or hypertension. Thus, the trend toward an increase in the odds for hypertension in 
participants in the “increasing depression” group could be seen as a consequence of depressive 
symptoms that are likely to be persistent, severe or less responsive-to-treatment. This could also 
explain why we observed that the risk of hypertension among men in the “increasing 
depression” group started to strengthen after the age of 55 years. Second, it has been proposed 
that depressive symptoms could be linked to hypertension through their effect on the autonomic 
nervous system involved in the regulation of blood pressure
32
. The effect of depressive 
symptoms on autonomic dysfunction could also be due to their association with other mental 
disorders, panic disorder in particular, rather than a direct effect 
33
. Third, depressive symptoms 
are associated with various health-related behaviours that could then impact the risk of 
hypertension. However, adjustment for smoking status, physical activity, alcohol intake and 
BMI at baseline did not alter the results in our study. Fourth, the observed association could be 
due to a common cause or a confounder. For instance, with aging there is a rapid increase in the 
risk of a number of medical conditions, such as cancer, diabetes, heart disease, and arthritis, 
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which are known to be associated with depression 
34, 35
. It is possible that the age-related 
increase in chronic medical conditions among older
 
individuals affects both the occurrence of 
depressive episode and hypertension, leading them to be associated when there is no causal 
association between the two. Finally, we cannot completely rule out the possibility of reverse 
causation since hypertension awareness may induce psychological distress 
36
. Further research is 
needed to clarify the precise mechanisms through which long-term patterns of depressive 
episodes are related to high blood pressure and its increase over time. Longitudinal modelling of 
some of the covariates included in this study may also allow better exploration of the 
mechanisms underlying the associations we have observed. 
Study limitations 
In interpreting the present results, it is important to note some limitations. First, this 
cohort of civil servants did not include blue collar and unemployed workers; thus it is not 
representative of the general population limiting the generalisability of our findings. Second, our 
data on depressive symptoms are limited to cognitive manifestations. Given that previous 
studies have shown clinical depression to be a stronger predictor of coronary heart disease than 
depressive mood 
5
, the present study may have underestimated the true association between 
depression and hypertension.  
Despite these potential limitations, the present findings are important as this is the first 
large-scale study to show the longitudinal patterns in the association of depressive episodes and 
hypertension, both assessed repeatedly over an extended follow-up period. The study provides 
robust evidence to suggest that increased depressive episodes over time are associated with a 
higher risk of hypertension which appears to become apparent in late adulthood (age 55+).  
Perspectives 
Our findings suggest that cross-sectional associations between depressive episodes and 
blood pressure in non-elderly populations might be uninformative. There seem to be both age- 
and time-related patterns of depressive episodes and thus it is reasonable to assume that long-
 14 
term patterns of depressive episodes over time may be more pertinent for hypertension than 
depressive episodes at a single point in time. Epidemiological studies with repeated measures 
are now widespread and our findings suggest that such data are important to examine the 
dynamics of the association between depressive symptoms and hypertension. 
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Table 1. Baseline characteristics in two depressive episodes trajectory groups 
 
 
Variables 
N total 
 
Depressive episodes trajectory groups 
 Low/transient 
N (%) 
Increasing 
N (%) 
p-value 
 
Age , Mean (SD) 10302 44.56 (6.06) 43.55 (5.89) <0.0001 
Sex    0.003 
    Women  3413 2981 (87.3) 432 (12.7)  
    Men 6889 6153 (89.3) 736 (10.7)  
Ethnicity    0.21 
    White  9177 8149 (88.8) 1028 (11.2)  
    Other 1125   985 (87.6)   140 (12.4)  
Marital status    <0.0001 
    Married/cohabiting 7603 6823 (89.7) 780 (10.3)  
    Other 2661 2278 (85.6) 383 (14.4)  
    Missing 38    33 (86.8)    5 (13.2)  
Socioeconomic status    0.0005 
    High 3027 2739 (90.5) 288 (9.5)  
    Intermediate 4939 4354 (88.2) 585 (11.8)  
    Low 2336 2041 (87.4) 295 (12.6)  
Physical activity    <0.0001 
    No 3261 2820 (86.5) 441 (13.5)  
    Yes 6529 5856 (89.7) 673 (10.3)  
    Missing 512  458 (89.5)  54 (10.5)  
Smoking status    0.30 
   Never 5062 4486 (88.6) 576 (11.4)  
   Ex 3269 2921 (89.4) 348 (10.6)  
   Current 1882 1649 (87.6) 233 (12.4)  
    Missing 89     78 (87.6)   11 (12.4)  
High alcohol intake    0.001 
    No 8609 7672 (89.1) 937 (10.9)  
    Yes 1599 1386 (86.7) 213 (13.3)  
    Missing 94     76 (80.9)    18 (19.1)  
BMI    0.022 
    <19.9 610   519 (85.1)   91 (14.9)  
    20-24.9 5642 4996 (88.6) 646 (11.4)  
    25-29.9 3314 2969 (89.6) 345 (10.4)  
    >30 726   642 (88.4)    84 (11.6)  
    Missing 10      8 (80.0)     2 (20.0)  
Cholesterol total >5mg/l    0.34 
    No 2241 1970 (87.9) 271 (12.1)  
    Yes 7989 7102 (88.9) 887 (11.1)  
    Missing 72     62 (86.1)   10 (13.9)  
Diabetes    0.915 
    No 10202 9045 (88.7) 1157 (11.3)  
    Yes 100    89 (89.0)    11 (11.0)  
History of myocardial infarction    0.58 
    No 10267 9104 (88.7) 1163 (11.3)  
    Yes 35    30 (85.7)                 5 (14.3)  
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History of stroke    0.97 
    No 10275 9110 (88.7) 1165 (11.3)  
    Yes 27 24 (88.9) 3 (11.1)  
History of cancer    0.98 
    No 10188 9033 (88.7) 1155 (11.3)  
   Yes 114 101 (88.6) 13 (11.4)  
Antihypertensive medication    0.86 
  No 9967 8836 (88.7) 1131 (11.3)  
  Yes 335 298 (89.0) 37 (11.0)  
Antidepressive medication    <0.0001 
  No 10180 9073 (89.1) 1107 (10.9)  
  Yes 122 61 (50.0) 61 (50.0)  
SBP, Mean (SD) 10290 123.32 (14.79) 121.20 (14.41) <0.0001 
DBS, Mean (SD) 10289 77.03 (10.24) 76.05 (10.14) 0.0022 
 
Note: BMI, body mass index; MI, myocardial infarction; SBP, systolic blood pressure; DBP, diastolic 
blood pressure 
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Table 2. Associations between trajectories of depressive episodes and probability of hypertension over time 
 
 
 
 
 
Variables 
Odds ratios (95% CI) for hypertension over time 
 
Men & Women 
N  observations = 
40599 
Men 
N observations = 
27922 
 
Women 
N  observations = 
12677  
Model 1    
Depressive episodes trajectory groups    
         low/transient depression 1 1 1 
         increasing depression 0.75 (0.61, 0.92) † 0.76 (0.59, 0.97) * 0.69 (0.47, 1.01)  
Depressive episodes trajectory groups x age    
         low/transient depression 1 1 1 
         increasing depression 1.07 (1.03,1.12) † 1.10 (1.04, 1.15) ‡ 1.04 (0.97, 1.12)  
 
Model 2 
 
 
 
Depressive episodes trajectory groups    
         low/transient depression 1 1 1 
         increasing depression 0.76 (0.62, 0.94) * 0.76 (0.59, 0.98) * 0.71 (0.48, 1.04)  
Depressive episodes trajectory groups x age    
         low/transient depression 1 1 1 
         increasing depression 1.07 (1.03, 1.12) † 1.10 (1.04, 1.15) ‡ 1.05 (0.97, 1.13)  
 
Model 3 
 
 
 
Depressive episodes trajectory groups    
         low/transient depression 1 1 1 
         increasing depression 0.75 (0.61, 0.92) † 0.76 (0.59, 0.97) * 0.69 (0.47, 1.02)  
Depressive episodes trajectory groups x age    
         low/transient depression 1 1 1 
         increasing depression 1.07 (1.03, 1.12) † 1.10 (1.04, 1.15) ‡  1.04 (0.97, 1.12)  
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Model 4 
 
 
 
Depressive episodes trajectory groups    
         low/transient depression 1 1 1 
         increasing depression 0.76 (0.62, 0.94) * 0.76 (0.59, 0.98) * 0.71 (0.49, 1.04)  
Depressive episodes trajectory groups x age    
         low/transient depression 1 1 1 
         increasing depression 1.07 (1.03, 1.12) † 1.09 (1.04, 1.15) ‡ 1.04 (0.97, 1.13)  
 
*p <0.05; † p<0.01; ‡ p<0.001 
Model 1: OR adjusted for sex, age, sex xage, ethnicity, marital status, marital status * age, socioeconomic status and 
socioeconomic status and age  
Model 2: Model 1 additionally adjusted for physical activity, smoking status, smoking status * age, bmi and cholesterol 
Model 3: Model 1 additionally adjusted for diabetes, history of myocardial infarction, history of stroke, history of cancer, 
history of cancer * age 
Model 4: Model 1 additionally adjusted for all aforementioned variables 
Note: In each model there are two ORs. The first estimates the association between depressive episodes trajectory groups and 
probability of hypertension at ages 35-39 (reference). The second estimates the proportional change in this association for 
every 5-years increase in age. 
 
 
 
 
